A group of natural compounds attracting attention for their anti-aging potential has a dark side. New research shows how a ...
News-Medical.Net on MSN
Low baseline testosterone predicts aggressive prostate cancer progression risk
A new study led by researchers at The University of Texas MD Anderson Cancer Center found that prostate cancer patients with low testosterone levels may have a higher risk of cancer progressing to a ...
Spermidine, a polyamine, has been linked to longer lifespans, improved health, and lessening memory loss with age, and it’s ...
A phase 3 trial of Roche’s giredestrant in first-line breast cancer patients has missed its primary endpoint, tarnishing the record of a drug that hit the mark in adjuvant and second-line settings.
They discovered a high-fat diet accelerates tumor growth and invasion. They also found it causes an increase in the enzyme ...
Researchers at the Cancer Research Institute and the Nano Life Science Institute (WPI-NanoLSI), Kanazawa University, have ...
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today results from the Phase III persevERA Breast Cancer study evaluating investigational giredestrant in combination ...
GLP-1 receptor agonists were not associated with recurrence or progression in well differentiated thyroid cancer, supporting ...
But I'm not sure what the intermediate stages are.
This guide will help you understand how throat cancer is diagnosed and what your diagnosis means. Learning as much as you can may help you feel ready to talk with doctors about your care. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results